Royal Brompton Hospital is the largest specialist heart and lung medical centre in the United Kingdom. It is managed by Guy's and St Thomas' NHS Foundation Trust.

During the past decade, Royal Brompton Hospital conducted 205 clinical trials. In the 10-year time frame, 205 clinical trials started and 76 clinical trials were completed, i.e. on average, 37.1% percent of trials that started reached the finish line to date. In the past 5 years, 80 clinical trials started and 63 clinical trials were completed. i.e. 78.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Brompton Hospital" #1 sponsor was "Royal Brompton & Harefield NHS Foundation Trust" with 70 trials, followed by "Imperial College London" with 47 trials sponsored, "Vertex Pharmaceuticals Incorporated" with 19 trials sponsored, "Boehringer Ingelheim" with 10 trials sponsored and "Abbott Medical Devices" with 10 trials sponsored. Other sponsors include 159 different institutions and companies that sponsored additional 112 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Brompton Hospital" #1 collaborator was "Royal Brompton & Harefield NHS Foundation Trust" with 35 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 12 trials as a collaborator, "Imperial College London" with 8 trials as a collaborator, "British Heart Foundation" with 6 trials as a collaborator and "University of Edinburgh" with 6 trials as a collaborator. Other collaborators include 209 different institutions and companies that were collaborators in the rest 162 trials.

According to Clinical.Site data, the most researched conditions in "Royal Brompton Hospital" are "Cystic Fibrosis" (49 trials), "Idiopathic Pulmonary Fibrosis" (26 trials), "Heart Failure" (20 trials), "Asthma" (17 trials) and "Chronic Obstructive Pulmonary Disease" (13 trials). Many other conditions were trialed in "Royal Brompton Hospital" in a lesser frequency.

Most popular intervention types in "Royal Brompton Hospital" are "Drug" (124 trials), "Device" (91 trials), "Other" (54 trials), "Procedure" (24 trials) and "Diagnostic Test" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (57 trials), "IVA" (18 trials), "ELX/TEZ/IVA" (11 trials), "Nintedanib" (5 trials) and "TEZ/IVA" (5 trials). Other intervention names were less common.

The vast majority of trials in "Royal Brompton Hospital" are 315 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are 68 active trials in "Royal Brompton Hospital". 6 are not yet recruiting, 39 are recruiting, 21 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 181 completed trials in Royal Brompton Hospital, 1 suspended trials, and 28 terminated clinical trials to date.

Out of the total trials that were conducted in Royal Brompton Hospital, 13 "Phase 1" clinical trials were conducted, 64 "Phase 2" clinical trials and 64 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 18 trials, and there were also 85 trials that are defined as “Not Applicable".

Royal Brompton Hospital has several departments that took part in Clinical trials: "Royal Brompton Hospital; Respiratory Department" - 6 trials, "Department of Nuclear Medicine, Royal Brompton Hospital" - 2 trials